Welcome to HitGen

News

Get up to date with the latest HitGen articles and join us in the events

  1. News
  2. Industry News

Pulmonary fibrosis model: Bleomycin-induced pulmonary fibrosis in mice Release Time:2025-04-24

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease characterized by fibrotic tissue replacing normal lung parenchyma, leading to declined pulmonary function and dyspnea.  

 

The bleomycin-induced pulmonary fibrosis model is widely used in scientific research to study the pathogenesis of pulmonary fibrosis and evaluate potential therapies. This model offers advantages such as high reproducibility, histopathological similarities to human pulmonary fibrosis, low cost, and operational simplicity. However, it exhibits acute and uneven fibrotic lesions, contrasting with the chronic progression and irreversibility of human IPF. Despite its limitations, this model remains indispensable in pulmonary fibrosis research and therapeutic development.


Thanks for reading!

For more details on how we can advance your innovative drug discovery projects
验证码
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information